Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Intraperitoneal alpha-radioimmunotherapy in mice using different specific activities

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Shelf-life of ɛ-lysyl-3-(trimethylstannyl)benzamide immunoconjugates, precursors for 211At labeling of antibodies

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Sequential radioimmunotherapy with 177Lu- and 211At-labeled monoclonal antibody BR96 in a syngeneic rat colon carcinoma model

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Comparison of (211)At-PRIT and (211)At-RIT of Ovarian Microtumors in a Nude Mouse Model

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Evaluation of effects on the peritoneum after intraperitoneal α-radioimmunotherapy with (211)At

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Various functions of PBMC from colon cancer patients are not decreased compared to healthy blood donors.

    Research output: Contribution to journalJournal articleResearch

View graph of relations
The aim of this study was to investigate the therapeutic efficacy of the alpha-radioimmunotherapy of ovarian cancer in mice, using different specific activities. This study was performed by using the monoclonal antibody, MX35 F(ab')(2), labeled with the alpha-particle-emitter, 211At.
Original languageEnglish
JournalCancer Biotherapy & Radiopharmaceuticals
Volume24
Issue number4
Pages (from-to)509-13
Number of pages5
ISSN1084-9785
DOIs
Publication statusPublished - 1 Aug 2009

ID: 32158868